SynthesisInternational journal of molecular medicine2017

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.

Yuze Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.